EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Onametostat, a PfPRMT5 inhibitor, exhibits antimalarial activity to Plasmodium falciparum

Hui Min, Amuza Byaruhanga Lucky, Jesper J Madsen, Anongruk Chim-Ong, Xiaolian Li, Liwang Cui iD, Jun Miao iD

Antimicrobial Agents and Chemotherapy · 2024

DOI: 10.1128/aac.00176-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Hui Min und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA. Hauptthemen laut MEDLINE: Plasmodium falciparum, Antimalarials, Protein-Arginine N-Methyltransferases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), USF | Morsani College of Medicine (MCOM), NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein arginine methyltransferases (PRMTs) play critical roles in Plasmodium falciparum , a protozoan causing the deadliest form of malaria, making them potential targets for novel antimalarial drugs. Here, we screened 11 novel PRMT inhibitors against P. falciparum asexual growth and found that onametostat, an inhibitor for type II PRMTs, exhibited strong antimalarial activity with a half-maximal inhibitory concentration (IC 50 ) value of 1.69 ± 0.04 µM. In vitro methyltransferase activities of purified PfPRMT5 were inhibited by onametostat, and a shift of IC 50 to onametostat was found in the PfPRTM5 disruptant parasite line, indicating that PfPRTM5 is the primary target of onametostat. Consistent with the function of PfPRMT5 in mediating symmetric dimethylation of histone H3R2 (H3R2me2s) and in regulating invasion-related genes, onametostat treatment led to the reduction of H3R2me2s level in P. falciparum and caused the defects on the parasite’s invasion of red blood cells. This study provides a starting point for identifying specific PRMT inhibitors with the potential to serve as novel antimalarial drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasmodium falciparumAntimalarialsProtein-Arginine N-MethyltransferasesErythrocytesProtozoan ProteinsHumansInhibitory Concentration 50HistonesMalaria, FalciparumEnzyme Inhibitors

Stichwörter der Autor:innen

PRMTPlasmodium falciparumantimalarialsarginine methylation

Substanzen

AntimalarialsProtein-Arginine N-MethyltransferasesProtozoan ProteinsHistonesEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.
  • Department of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
  • Center for Global Health and Infectious Diseases Research, College of Public Health, University of South Florida, Tampa, Florida, USA.
  • Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.

ORCID-Profile: Liwang Cui, Jun Miao

Förderung

  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
  • USF | Morsani College of Medicine (MCOM)
  • NIAID NIH HHS

Zitieren

APA

Min, H., Lucky, A. B., Madsen, J. J., Chim-Ong, A., Li, X., Cui, L., & Miao, J. (2024). Onametostat, a PfPRMT5 inhibitor, exhibits antimalarial activity to Plasmodium falciparum. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00176-24

Vancouver

Min H, Lucky AB, Madsen JJ, Chim-Ong A, Li X, Cui L, et al. Onametostat, a PfPRMT5 inhibitor, exhibits antimalarial activity to Plasmodium falciparum. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00176-24

BibTeX
@article{Min2024,
  author = {Min, Hui and Lucky, Amuza Byaruhanga and Madsen, Jesper J and Chim-Ong, Anongruk and Li, Xiaolian and Cui, Liwang and Miao, Jun},
  title = {Onametostat, a PfPRMT5 inhibitor, exhibits antimalarial activity to Plasmodium falciparum},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  doi = {10.1128/aac.00176-24}
}
Kostenlos starten →